Events Calendar
6th annual conference Clinical Trials for Alzheimer’s Disease (CtaD) 2013. San Diego, California. Nov 14-16, 2013
Dr. M. Agadjanyan gave a talk entitled: ‘MultiTEP platform based AD vaccine immunogenic in rabbits and monkeys’.
11th International Conference on Alzheimer’s and Parkinson’s disease (AD/PD). Florence, Italy. March 6-10, 2013
Dr. A. Ghochikyan gave a talk entitled: ‘DNA-based epitope vaccine: broad coverage of MHC polymorphism and targeting pre-existing memory T cell’
4th Annual Emerging Scientists Symposium, ReMIND. University of California, Irvine, California. February 21, 2013
Dr. H. Davtyan gave a talk entitled: ‘Multiple approaches to immunotherapy against Alzheimer’s disease’
X Immunology Fair. University of California, Irvine, California. November 15-16, 2012
Ms. A. Davtyan presented data on: ‘Primary breast 4T1 tumor resection model for the testing for anti-cancer therapeutics’.
Alzheimer’s Association International Conference (AAIC), Vancouver, Canada. July 14-19, 2012
Dr. H. Davtyan presented data on: ‘Refinement of DNA based Alzheimer’s disease epitope vaccine in rabbits’.
The Alzheimer’s Association 1st Brainwaves Research Symposium. Santa Barbara, California. April 19, 2012
Dr. H. Davtyan presented data on: ‘Multiple approaches to immunotherapy against Alzheimer’s disease’.
The International Society of DNA Vaccines “DNA Vaccines 2011” Conference: Building on Clinical Progress and Exploring New Targets. San Diego, California. July 12-14, 2011
Dr. A. Ghochikyan presented data on: ‘Refinement of Alzheimer’s Disease (AD) DNA Vaccine Efficacy by Targeting Pre-Existing Memory Th Cells Generated from Conventional Vaccines or Infections’.
10th International Conference on Alzheimer’s and Parkinson’s disease (AD/PD). Barcelona, Spain. March 9-14, 2011
Institute for Molecular Medicine was selected for two lectures. Dr. M. Agadjanyan gave a talk entitled: ‘Alzheimer’s Disease Epitope Vaccine’. And Dr. A. Ghochikyan presented data on: ‘A Novel Strategy for Generation of Effective and Safe Alzheimer’s Disease Vaccine Based on Conventional Influenza Virus Vaccine Modified to Express Ab1-10′.
International Conference on Alzheimer’s Disease (ICAD). Honolulu, Hawaii. July 10-15, 2010
Dr. H. Davtyan will present data on: ‘Exploiting prime-boost regimen and various delivery strategies to improve Alzheimer’s Disease DNA vaccine efficacy’.
American Association of Cancer Research (AACR) 101st Annual Meeting: Conquering Cancer Through Discovery Research. Washington, DC. April 17-21, 2010
Our late breaking abstract (on pre-clinical research) was chosen as a part of a Media Outreach Press Conference, with four clinical studies. Dr. Agadjanyan represented this work in a one hour conference, entitled ‘A Multidisciplinary Approach to Cancer Detection and Treatment: What’s On the Horizon’, on Sunday, April 18th, 2010. The study outlined in abstract entitled ‘A novel cancer-testis antigen, BORIS based vaccine delivered by Dendritic Cells is effective against metastatic disease’, submitted by IMM research groups in collaboration with various groups (from the UCI Immunology Institute lead by Dr. E. Nelson, from NIAID Immunopathology Lab lead by Dr. Lobannekov, and group from the Institute of Immunology, Russian academy of medical Sciences lead by Dr. Ataullakhanov) has been identified as newsworthy.
The International Society of DNA Vaccines 4th ‘DNA Vaccines 2010’ Conference: Expanding Applications of the DNA Vaccine Platform – Novel Research and Clinical Advancement. New Orleans, Louisiana. March 2-4, 2010
Dr. M. Agadjanyan gave a talk entitled: ‘DNA Vaccine Based on Cancer-Testis Antigen, BORIS and IL21 Molecular Adjuvant in Extremely Effective For Treatment of Metastatic Disease’. Dr. Ghochikyan gave a talk entitled: ‘Improvement of Alzheimer’s Disease (AD) DNA Vaccine Efficacy by DNA Prime/Protein Boost Regimen in Mice and Rabbits’.
International Conference on Alzheimer’s Disease (ICAD ). Vienna, Austria. July 11-16, 2009
Dr. A. Ghochikyan gave a talk entitled: ‘Induction of rapid and robust anti-Aβ antibody production by reactivation of pre-existing memory Th cells generated from conventional vaccines’
9th International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD): Advances, Concepts and Challenges. Prague, Czech Republic. March 11-15, 2009
Dr. A. Ghochikyan gave a talk entitled: ‘Third generation epitope vaccine (EV):A new Strategy for amyloid betta (Ab) immunotherapy’.
D5 Creation